Carmine Stengone

Carmine Stengone

Algemeen Directeur bij CONTINEUM THERAPEUTICS, INC.

Vermogen: 205 079 $ op 31-05-2026

50 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Mr. Carmine N.
Stengone
is an Independent Director at Kiora Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Contineum Therapeutics, Inc. He is on the Board of Directors at Kiora Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. Mr. Stengone was previously employed as a Senior Vice President-Business Development by COI Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avelas Biosciences, Inc., a President, Chief Executive Officer & Director by Afraxis, Inc., a Senior Director-Business Development by Phenomix Corp., a Senior Manager-Strategic Marketing by Anadys Pharmaceuticals, Inc., and a Principal by Johnson & Johnson Pharmaceutical Research & Development LLC.
He received his undergraduate degree from Wake Forest University, a graduate degree from Duke University and an MBA from Johnson Graduate School of Management.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
17-04-2026 14.954 ( 0,05% ) 201 729 $ 31-05-2026
10-06-2026 1.250 ( 0,03% ) 3 350 $ 31-05-2026

Actieve functies van Carmine Stengone

BedrijvenFunctieBegin
CONTINEUM THERAPEUTICS, INC. Algemeen Directeur 01-10-2018
KIORA PHARMACEUTICALS, INC. Directeur/Bestuurslid 01-08-2023

Eerdere bekende functies van Carmine Stengone

BedrijvenFunctieEinde
Algemeen Directeur 01-01-2018
Corporate Officer/Principal 01-10-2018
Corporate Officer/Principal 28-10-2010
Verkoop & Marketing 01-01-2006
Corporate Officer/Principal 01-01-2004
Ervaring van Carmine Stengone in detail bekijken

Opleiding van Carmine Stengone

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

88

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Carmine Stengone
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU